Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Nasopharyngeal Carcinoma 14 Triple Negative Breast Neoplasms 12 Carcinoma, Non-Small-Cell Lung 10 Esophageal Squamous Cell Carcinoma 8 Breast Neoplasms 8 Colorectal Neoplasms 7 Carcinoma, Renal Cell 7 Small Cell Lung Carcinoma 6 Neoplasms 6 Advanced Solid Tumor 6 Uterine Cervical Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 5 Urinary Bladder Neoplasms 4 Recurrence 4 Head and Neck Neoplasms 4 Carcinoma, Hepatocellular 4 Stomach Neoplasms 3 Solid Tumor 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Carcinoma, Transitional Cell 3 Turcot syndrome 2 Sarcoma 2 Oropharyngeal Neoplasms 2 NSCLC 2 Muscle Invasive Bladder Cancer (MIBC) 2 Carcinoma, Squamous Cell 2 Biliary Tract Neoplasms 2 Advanced Solid Tumors 2 Advanced Lung Cancer 2

Interventions

Cisplatin 7 Gemcitabine 6 pembrolizumab 4 Radiotherapy, Intensity-Modulated 4 Bevacizumab 2 toripalimab 1 tocilizumab 1 tislelizumab 1 spartalizumab 1 penpulimab 1 atezolizumab 1 Vitamin D 1 Tablets 1 Surveys and Questionnaires 1 Phantoms, Imaging 1 Oral Hygiene 1 Observation 1 Magnetic Resonance Spectroscopy 1 Immunotherapy 1 Immunohistochemistry 1 Immunoglobulin G 1 Fluorouracil 1 Disulfides 1 Dexamethasone 1 Chemoradiotherapy 1 Cetuximab 1 Carboplatin 1 Capecitabine 1 Blood Specimen Collection 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Nasopharyngeal Neoplasms × toripalimab × 1 year × Clear all

NCT06457503 2026-04-06

TRANSPARENT

Coherus Oncology, Inc.

Phase 4 Recruiting

Nasopharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡